Search

Displaying results 6921 - 6930 of 7893 in total
  1. Drug

    FRAX1036

    go.drugbank.com/drugs/DB31834
    Experimental

    FRAX1036 is a p21-activated kinase (PAK) inhibitor.

  2. Drug

    SCY-247

    go.drugbank.com/drugs/DB32724
    Experimental

    SCY-247 is a second generation triterpenoid.

  3. Drug

    GLB-004

    go.drugbank.com/drugs/DB32796
    Experimental

    GLB-004 is a molecular glue degrader targeting ARNT(HIF-1β).[L56125, L56126]

  4. Drug

    GLB-005

    go.drugbank.com/drugs/DB32797
    Experimental

    GLB-005 is a molecular glue degrader targeting WIZ and is being investigated for treatment of sickle cell disease and β-thalassemia.[L56125, L56126, L56128]

  5. Drug

    GLB-007

    go.drugbank.com/drugs/DB32798
    Experimental

    GLB-007 is a molecular glue degrader targeting WIZ and ZBTB7A.[L56125, L56126, L56128]

  6. Drug

    GLB-006

    go.drugbank.com/drugs/DB32799
    Experimental

    GLB-006 is a molecular glue degrader targeting NEK7.[L56125, L56126]

  7. Drug

    APT20TTMG

    go.drugbank.com/drugs/DB32869
    Experimental

    APT20TTMG is a synthetic DNA that modulates U1 small nuclear ribonucleoprotein misassembly.

  8. Drug

    Epertinib

    go.drugbank.com/drugs/DB20062
    Experimental

    Epertinib has a monoisotopic molecular weight of 559.18 Da. … Epertinib is a small molecule drug. The usage of the INN stem '-ertinib' in the name indicates that Epertinib is a epidermal growth factor receptor (EGFR) inhibitor.

  9. Drug

    Rifamexil

    go.drugbank.com/drugs/DB20067
    Experimental

    Rifamexil is a small molecule drug. Rifamexil has a monoisotopic molecular weight of 809.36 Da.

  10. Drug

    Valactate

    go.drugbank.com/drugs/DB20086
    Experimental

    Valactate is a small molecule drug. Valactate has a monoisotopic molecular weight of 188.09 Da.